Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 47

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 47
---
0.1%          |
| William Elder, Chief Financial Officer & General Counsel (13)                         |               27,612 | 0.3%          |
| All Directors, Director Nominees, and Executive Officers as a Group (11 persons) (14) |            3,182,179 | 35.4%         |
| Other 5% Stockholders:                                                                |                      |               |
| RA Capital Management, L.P. (15)                                                      |              916,063 | 9.9%          |
| Armistice Capital Master Fund L.P. (16)                                               |              734,363 | 7.8%          |

* Indicates less than 1.0%

| 1) | Includes shares of common stock held as of April 24, 2025, the Record Date, plus shares of common stock that may be acquired upon exercise of options, warrants and other rights exercisable within 60 days of the Record Date.                                                                                                                                                                                                                                                                                                                                                                     |
|:---|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2) | Based on 8,702,719 shares of common stock issued and outstanding as of the Record Date. The percentage ownership and voting power for each person (or all directors and executive officers as a group) is calculated by assuming (i) the exercise or conversion of all options, warrants and convertible securities exercisable or convertible within 60 days of the Record Date held by such person and (ii) the non-exercise and non-conversion of all outstanding warrants, options and convertible securities held by all other persons (including our other directors and executive officers). |

| 3) | Consists of (a) 1,461,578 shares of common stock held jointly by Dr. Alam and Dr. Grégoire, his spouse, (b) 44,137 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date held by Dr. Alam and (c) 9,512 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date held by Dr. Grégoire. Dr. Alam disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |

<div align='center'>25</div>

| 4) | Consists of (a) 216,817 shares of common stock held directly by Dr. Boger, (b)